Jones Financial Companies’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.04M | Buy |
72,659
+8,926
| +14% | +$988K | 0.01% | 398 |
|
|
2025
Q1 | $7.12M | Buy |
63,733
+11,929
| +23% | +$1.33M | 0.01% | 361 |
|
|
2024
Q4 | $4.79M | Buy |
51,804
+15,263
| +42% | +$1.41M | ﹤0.01% | 367 |
|
|
2024
Q3 | $3.06M | Buy |
36,541
+15,389
| +73% | +$1.29M | ﹤0.01% | 370 |
|
|
2024
Q2 | $1.45M | Buy |
21,152
+15,133
| +251% | +$1.04M | ﹤0.01% | 370 |
|
|
2024
Q1 | $441K | Buy |
6,019
+4,572
| +316% | +$335K | ﹤0.01% | 346 |
|
|
2023
Q4 | $117K | Buy |
1,447
+519
| +56% | +$42K | ﹤0.01% | 387 |
|
|
2023
Q3 | $69.5K | Hold |
928
| – | – | ﹤0.01% | 337 |
|
|
2023
Q2 | $71.5K | Sell |
928
-113
| -11% | -$8.71K | ﹤0.01% | 337 |
|
|
2023
Q1 | $86.4K | Buy |
1,041
+331
| +47% | +$27.5K | ﹤0.01% | 315 |
|
|
2022
Q4 | $61K | Buy |
710
+66
| +10% | +$5.67K | ﹤0.01% | 332 |
|
|
2022
Q3 | $40K | Hold |
644
| – | – | ﹤0.01% | 339 |
|
|
2022
Q2 | $40K | Hold |
644
| – | – | ﹤0.01% | 346 |
|
|
2022
Q1 | $38K | Sell |
644
-381
| -37% | -$22.5K | ﹤0.01% | 375 |
|
|
2021
Q4 | $74K | Hold |
1,025
| – | – | ﹤0.01% | 327 |
|
|
2021
Q3 | $72K | Sell |
1,025
-44
| -4% | -$3.09K | ﹤0.01% | 294 |
|
|
2021
Q2 | $74K | Sell |
1,069
-1,144
| -52% | -$79.2K | ﹤0.01% | 285 |
|
|
2021
Q1 | $143K | Buy |
2,213
+886
| +67% | +$57.3K | ﹤0.01% | 249 |
|
|
2020
Q4 | $77K | Buy |
+1,327
| New | +$77K | ﹤0.01% | 265 |
|
|
2013
Q4 | – | Sell |
-565
| Closed | -$36K | – | 358 |
|
|
2013
Q3 | $36K | Sell |
565
-161
| -22% | -$10.3K | ﹤0.01% | 342 |
|
|
2013
Q2 | $37K | Buy |
+726
| New | +$37K | ﹤0.01% | 354 |
|